Sign in
4

Changes in Ownership

Axsome Therapeutics, Inc. Filed Acc 0001193125-26-083609

Options or other derivatives

  • Chief Executive Officer acquired 54,623 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
TABUTEAU HERRIOT Chief Executive Officer 2026-02-26 Grant or award · Restricted Stock Units +54,623 54,623 D: show line 1 in the form
Loading xslF345X05/ownership.xml…